Zevra Therapeutics (ZVRA) Receivables - Other (2015 - 2024)
Zevra Therapeutics (ZVRA) reported Receivables - Other of $333000.0 for Q4 2024, down 73.53% on a YoY basis from $1.3 million in Q1 2024, and down 73.53% quarter-over-quarter from $1.3 million in Q4 2023.
Zevra Therapeutics (ZVRA) Receivables - Other (2015 - 2024) Analysis & Trends
Zevra Therapeutics has reported Receivables - Other for 10 years, with the latest figure at $333000.0 in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other fell 73.53% year-over-year to $333000.0; the trailing twelve-month figure through Dec 2024 stood at $333000.0 (down 73.53% YoY), and the FY2024 full-year result was $333000.0, down 73.53% from the prior year.
- Receivables - Other for Q4 2024 stood at $333000.0, down from $1.3 million in the prior quarter.
- The five-year high for Receivables - Other was $1.3 million in Q4 2023, with the low at $107000.0 in Q4 2021.
- Historically, Receivables - Other has averaged $504454.5 across 5 years, with a median of $400000.0 in 2021.
- Annual changes were most pronounced in 2022 — Receivables - Other jumped 941.12% — and 2024, when it plunged 73.53%.
- Zevra Therapeutics' Receivables - Other stood at $137000.0 in 2020, then slipped by 21.9% to $107000.0 in 2021, then jumped by 941.12% to $1.1 million in 2022, then increased by 12.93% to $1.3 million in 2023, then sank by 73.53% to $333000.0 in 2024.
- The last three Receivables - Other figures came in at $333000.0 (Q4 2024), $1.3 million (Q4 2023), and $700000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Zevra Therapeutics | 796.95 Mn | 596.33 Mn | 34.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 333,000.00 |
| Dec 31, 2024 | 333,000.00 |
| Dec 31, 2023 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Mar 31, 2023 | 700,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 1.11 Mn |
| Dec 31, 2022 | 1.11 Mn |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Dec 31, 2021 | 107,000.00 |
| Dec 31, 2021 | 107,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Mar 31, 2021 | 400,000.00 |
| Mar 31, 2021 | 400,000.00 |